Editorial
Year 2025,
, 325 - 333, 10.04.2025
Abstract
References
- 1. Bavaria JE, Szeto WY, Roche LA, et al. The progression of a transcatheter aortic valve program: a decision analysis of more than 680 patient referrals. The Annals of Thoracic Surgery. 2011;92(6):2072-7. DOI:10.1016/j.athoracsur.2011.06.060
- 2. Bakaeen FG, Kar B, Chu D, et al. Establishment of a transcatheter aortic valve program and heart valve team at a veterans affairs facility. The American Journal of Surgery. 2012;204(5):643-8. DOI:10.1016/j.amjsurg.2012.07.017
- 3. Hawkey MC, Lauck SB, Perpetua EM, et al. Transcatheter aortic valve replacement program development: recommendations for best practice. Catheterization and Cardiovascular Interventions. 2014;84(6):859-67. DOI:10.1002/ccd.25529
- 4. Johnson K. The evolution of the program coordinator: from one valve to the whole Heart. Structural Heart. 2019;3(1):18-9. DOI:10.1080/24748706.2018.1554928
- 5. Lauck S, Achtem L, Boone RH, et al. Implementation of processes of care to support transcatheter aortic valve replacement programs. European Journal of Cardiovascular Nursing. 2013;12(1):33-8. DOI:10.1016/j.ejcnurse.2011.06.005
- 6. Bennetts J, Sinhal A, Walters D, et al. 2021 CSANZ and ANZSCTS position statement on the operator and institutional requirements for a transcatheter aortic valve implantation (TAVI) program in Australia. Heart, Lung and Circulation. 2021;30(12):1811-8. DOI:10.1016/j.hlc.2021.07.017
- 7. Bohmann K, Burgdorf C, Zeus T, et al. The COORDINATE pilot study: impact of a transcatheter aortic valve coordinator program on hospital and patient outcomes. Journal of Clinical Medicine. 2022;11(5). DOI:10.3390/jcm11051205
- 8. De Ronde-Tillmans MJAG, Goudzwaard JA, El Faquir N, et al. TAVI Care and Cure, the Rotterdam multidisciplinary program for patients undergoing transcatheter aortic valve implantation: Design and rationale. International Journal of Cardiology. 2020;302:36-41. DOI:10.1016/j.ijcard.2019.12.005
- 9. Lortz J, Lortz TP, Johannsen L, et al. Clinical process optimization of transfemoral transcatheter aortic valve implantation. Future Cardiology. 2021;17(2):321-7. DOI:10.2217/fca-2020-0010
- 10. Van Wiechen MP, Ooms JF, Hokken TW, et al. Pathways towards lean TAVR. Structural Heart. 2020;4(4):284-7. DOI:10.1080/24748706.2020.1765056
- 11. Lauck SB, McCalmont G, Smith A, et al. Setting a benchmark for quality of care: Update on best practices in transcatheter aortic valve replacement programs. Critical Care Nursing Clinics of North America. 2022;34(2):215-31. DOI:10.1016/j.cnc.2022.02.009
- 12. Lauck SB, Smith A. The Heart Team: A gold standard of care. In: Hawkey MC, Lauck SB, editors. Valvular Heart Disease: A guide for cardiovascular nurses and allied health professionals. Cham: Springer International Publishing; 2022. p. 59-72.
- 13. Batchelor WB, Anwaruddin S, Wang DD, et al. The multidisciplinary heart team in cardiovascular medicine: Current role and future challenges. JACC: Advances. 2023;2(1):100160. DOI:10.1016/j.jacadv.2022.100160
- 14. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n71. DOI:10.1136/bmj.n71
- 15. Lauck S., Sathananthan J., Achtem L., et al. Nurse-led post-procedure protocol to facilitate safe next-day discharge home: Findings of the 3M TAVR study. Canadian Journal of Cardiology. 2019;35(10):204.
- 16. Adhami N, Rozor M, Percy C, et al. The road to a transcatheter edge-to-edge repair: patient experiences leading up to the procedure and in the early recovery period. European Journal of Cardiovascular Nursing. 2023;22(5):463-71. DOI:10.1093/eurjcn/zvac066
- 17. Lauck SB, Wood DA, Baumbusch J, et al. Vancouver transcatheter aortic valve replacement clinical pathway: Minimalist approach, standardized care, and discharge criteria to reduce length of stay. Circulation Cardiovascular quality and outcomes. 2016;9(3):312-21. DOI:10.1161/CIRCOUTCOMES.115.002541
- 18. Perpetua EM, Russo MJ. Never let a crisis go to waste: What have we learned about clinical pathways for transcatheter structural heart interventions? Structural Heart. 2021;5(6):605-7. DOI:10.1080/24748706.2021.2006384
- 19. Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: The 3M TAVR study. Cardiovascular Interventions. 2019;12(5):459-69. DOI:10.1016/j.jcin.2018.12.020
- 20. Clarke SE. Imaging modalities in the diagnosis and treatment of acquired heart valve disease. Valvular Heart Disease: A Guide for Cardiovascular Nurses and Allied Health Professionals. 2022:89-121.
- 21. Tchetche D, de Biase C, Brochado B, et al. How to make the TAVI pathway more efficient. Interventional Cardiology Review. 2019;14(1):31. DOI:10.15420/icr.2018.28.2
- 22. Perpetua EM, Clarke SE, Guibone KA, et al. Surveying the landscape of structural heart disease coordination: An exploratory study of the coordinator role. Structural Heart-the Journal of the Heart Team. 2019;3(3):201-10. DOI:10.1080/24748706.2019.1581962
- 23. Neuburger PJ, Luria BJ, Rong LQ, et al. Operational and institutional recommendations and requirements for TAVR: A review of expert consensus and the impact on health care policy. Journal of Cardiothoracic and Vascular Anesthesia. 2019;33(6):1731-41. DOI:10.1053/j.jvca.2019.01.062
- 24. Hawkey MC, Lauck SB. Valvular Heart Disease: A Guide for cardiovascular nurses and allied health professionals: Springer; 2022.
- 25. Frantzen AT, Lauck SB, Norekvål TM. Measuring function, frailty and quality of life in people with heart valve disease. Valvular Heart Disease: A Guide for Cardiovascular Nurses and Allied Health Professionals. 2022:123-33.
- 26. Lauck S, Forman J, Borregaard B, et al. Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes. European Journal of Cardiovascular Nursing. 2020;19(6):537-44. DOI:10.1177/1474515120934057
- 27. Almanfi A. The Key Elements That are Fundamental for Initiating a Structural Heart Program. Structural Heart. 2018;2(3):197-8. DOI: 10.1080/24748706.2018.1446110
- 28. Speight MK. Transcatheter treatment options for acquired valvular heart disease. Valvular Heart Disease: A Guide for Cardiovascular Nurses and Allied Health Professionals. 2022:167-89.
- 29. Straiton N, Johnston R, Martin L. 826 examining structural heart disease care management: an exploratory study of the coordinator role. Heart, Lung and Circulation. 2020;29:S409. DOI:10.1016/j.hlc.2020.09.833
- 30. Perpetua EM, Guibone KA, Keegan PA, et al. Best practice recommendations for optimizing care in structural heart programs: planning efficient and resource leveraging systems (PEARLS). Structural Heart. 2021;5(2):168-79. DOI:10.1080/24748706.2021.1877858
A SYSTEMATIC REVIEW ON THE RESULTS OF THE COORDINATOR APPROACH IN TRANSCATHETER AORTIC VALVE IMPLANTATION
Abstract
Background/Purpose: Communication and coordination between the patient, family, and heart team members remain a managerial challenge, although the heart team approach considers the Transcatheter Aortic Valve Implantation (TAVI) management multidimensional. The managerial difficulties of the TAVI have been overcome by a coordinator, usually a nurse, who is called the TAVI coordinator. This systematic review aims to holistically reveal the results of the coordination approach in TAVI management.
Methods: With the search designed based on study purpose in databases, 445 studies were identified [Science Direct (n=259), Scopus (n=62), Google Scholar (n=43), Medline+TR Index (n=13), PubMed (n=12), Web of Science (n=10), Emerald (n=4), Citations (n=42)]. Twenty-eight (28) studies were synthesized after systematic screening based on study criteria. The systematic review process used a systematic search and review typology. The research process was implemented based on the "PRISMA" checklist.
Results: Results indicated that TAVI or valve structural heart coordination accelerates the pathway, increases patient satisfaction, optimizes resource use, and reduces costs, helping to prevent medical error.
Conclusion: This study reveals the positive results of the coordination approach on the team, patient and hospital. It brings the approach to the agenda of clinic and hospital managers as a managerial tool.
References
- 1. Bavaria JE, Szeto WY, Roche LA, et al. The progression of a transcatheter aortic valve program: a decision analysis of more than 680 patient referrals. The Annals of Thoracic Surgery. 2011;92(6):2072-7. DOI:10.1016/j.athoracsur.2011.06.060
- 2. Bakaeen FG, Kar B, Chu D, et al. Establishment of a transcatheter aortic valve program and heart valve team at a veterans affairs facility. The American Journal of Surgery. 2012;204(5):643-8. DOI:10.1016/j.amjsurg.2012.07.017
- 3. Hawkey MC, Lauck SB, Perpetua EM, et al. Transcatheter aortic valve replacement program development: recommendations for best practice. Catheterization and Cardiovascular Interventions. 2014;84(6):859-67. DOI:10.1002/ccd.25529
- 4. Johnson K. The evolution of the program coordinator: from one valve to the whole Heart. Structural Heart. 2019;3(1):18-9. DOI:10.1080/24748706.2018.1554928
- 5. Lauck S, Achtem L, Boone RH, et al. Implementation of processes of care to support transcatheter aortic valve replacement programs. European Journal of Cardiovascular Nursing. 2013;12(1):33-8. DOI:10.1016/j.ejcnurse.2011.06.005
- 6. Bennetts J, Sinhal A, Walters D, et al. 2021 CSANZ and ANZSCTS position statement on the operator and institutional requirements for a transcatheter aortic valve implantation (TAVI) program in Australia. Heart, Lung and Circulation. 2021;30(12):1811-8. DOI:10.1016/j.hlc.2021.07.017
- 7. Bohmann K, Burgdorf C, Zeus T, et al. The COORDINATE pilot study: impact of a transcatheter aortic valve coordinator program on hospital and patient outcomes. Journal of Clinical Medicine. 2022;11(5). DOI:10.3390/jcm11051205
- 8. De Ronde-Tillmans MJAG, Goudzwaard JA, El Faquir N, et al. TAVI Care and Cure, the Rotterdam multidisciplinary program for patients undergoing transcatheter aortic valve implantation: Design and rationale. International Journal of Cardiology. 2020;302:36-41. DOI:10.1016/j.ijcard.2019.12.005
- 9. Lortz J, Lortz TP, Johannsen L, et al. Clinical process optimization of transfemoral transcatheter aortic valve implantation. Future Cardiology. 2021;17(2):321-7. DOI:10.2217/fca-2020-0010
- 10. Van Wiechen MP, Ooms JF, Hokken TW, et al. Pathways towards lean TAVR. Structural Heart. 2020;4(4):284-7. DOI:10.1080/24748706.2020.1765056
- 11. Lauck SB, McCalmont G, Smith A, et al. Setting a benchmark for quality of care: Update on best practices in transcatheter aortic valve replacement programs. Critical Care Nursing Clinics of North America. 2022;34(2):215-31. DOI:10.1016/j.cnc.2022.02.009
- 12. Lauck SB, Smith A. The Heart Team: A gold standard of care. In: Hawkey MC, Lauck SB, editors. Valvular Heart Disease: A guide for cardiovascular nurses and allied health professionals. Cham: Springer International Publishing; 2022. p. 59-72.
- 13. Batchelor WB, Anwaruddin S, Wang DD, et al. The multidisciplinary heart team in cardiovascular medicine: Current role and future challenges. JACC: Advances. 2023;2(1):100160. DOI:10.1016/j.jacadv.2022.100160
- 14. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n71. DOI:10.1136/bmj.n71
- 15. Lauck S., Sathananthan J., Achtem L., et al. Nurse-led post-procedure protocol to facilitate safe next-day discharge home: Findings of the 3M TAVR study. Canadian Journal of Cardiology. 2019;35(10):204.
- 16. Adhami N, Rozor M, Percy C, et al. The road to a transcatheter edge-to-edge repair: patient experiences leading up to the procedure and in the early recovery period. European Journal of Cardiovascular Nursing. 2023;22(5):463-71. DOI:10.1093/eurjcn/zvac066
- 17. Lauck SB, Wood DA, Baumbusch J, et al. Vancouver transcatheter aortic valve replacement clinical pathway: Minimalist approach, standardized care, and discharge criteria to reduce length of stay. Circulation Cardiovascular quality and outcomes. 2016;9(3):312-21. DOI:10.1161/CIRCOUTCOMES.115.002541
- 18. Perpetua EM, Russo MJ. Never let a crisis go to waste: What have we learned about clinical pathways for transcatheter structural heart interventions? Structural Heart. 2021;5(6):605-7. DOI:10.1080/24748706.2021.2006384
- 19. Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: The 3M TAVR study. Cardiovascular Interventions. 2019;12(5):459-69. DOI:10.1016/j.jcin.2018.12.020
- 20. Clarke SE. Imaging modalities in the diagnosis and treatment of acquired heart valve disease. Valvular Heart Disease: A Guide for Cardiovascular Nurses and Allied Health Professionals. 2022:89-121.
- 21. Tchetche D, de Biase C, Brochado B, et al. How to make the TAVI pathway more efficient. Interventional Cardiology Review. 2019;14(1):31. DOI:10.15420/icr.2018.28.2
- 22. Perpetua EM, Clarke SE, Guibone KA, et al. Surveying the landscape of structural heart disease coordination: An exploratory study of the coordinator role. Structural Heart-the Journal of the Heart Team. 2019;3(3):201-10. DOI:10.1080/24748706.2019.1581962
- 23. Neuburger PJ, Luria BJ, Rong LQ, et al. Operational and institutional recommendations and requirements for TAVR: A review of expert consensus and the impact on health care policy. Journal of Cardiothoracic and Vascular Anesthesia. 2019;33(6):1731-41. DOI:10.1053/j.jvca.2019.01.062
- 24. Hawkey MC, Lauck SB. Valvular Heart Disease: A Guide for cardiovascular nurses and allied health professionals: Springer; 2022.
- 25. Frantzen AT, Lauck SB, Norekvål TM. Measuring function, frailty and quality of life in people with heart valve disease. Valvular Heart Disease: A Guide for Cardiovascular Nurses and Allied Health Professionals. 2022:123-33.
- 26. Lauck S, Forman J, Borregaard B, et al. Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes. European Journal of Cardiovascular Nursing. 2020;19(6):537-44. DOI:10.1177/1474515120934057
- 27. Almanfi A. The Key Elements That are Fundamental for Initiating a Structural Heart Program. Structural Heart. 2018;2(3):197-8. DOI: 10.1080/24748706.2018.1446110
- 28. Speight MK. Transcatheter treatment options for acquired valvular heart disease. Valvular Heart Disease: A Guide for Cardiovascular Nurses and Allied Health Professionals. 2022:167-89.
- 29. Straiton N, Johnston R, Martin L. 826 examining structural heart disease care management: an exploratory study of the coordinator role. Heart, Lung and Circulation. 2020;29:S409. DOI:10.1016/j.hlc.2020.09.833
- 30. Perpetua EM, Guibone KA, Keegan PA, et al. Best practice recommendations for optimizing care in structural heart programs: planning efficient and resource leveraging systems (PEARLS). Structural Heart. 2021;5(2):168-79. DOI:10.1080/24748706.2021.1877858
There are 30 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Review |
| Authors | |
| Early Pub Date | March 21, 2025 |
| Publication Date | April 10, 2025 |
| Submission Date | February 10, 2024 |
| Acceptance Date | January 13, 2025 |
| Published in Issue | Year 2025 |